Mabimmune
Schlieren
About Mabimmune
Mabimmune specializes in the prevention of heart attacks through early diagnosis and targeted treatment. The company was founded in 2013 and is headquartered in Schlieren, Zurich.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $137.1K
- Funding stage: Seed
- Last round: Pre-Seed (Apr 2013)
- Website: mabimmune.com
Industries & Categories
Health Care, Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/mabimmune-3022289 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.